Ayurcann Holdings Corp. (CSE:AYUR) said it has filed an application to be quoted on the OTCQB, the US market operated by OTC Markets Group Inc. (OTCQX:OTCM) in New York.
The company noted that it will continue to trade on the Canadian Securities Exchange (CSE) under its symbol AYUR. In addition, Ayurcann said it is working to secure DTC eligibility with The Depository Trust Company (DTC) for electronic settlement and transfer of its common shares in the United States.
The OTC operates the world's largest electronic interdealer quotation system for US broker-dealers and offers multiple media channels to increase the visibility of OTC-listed companies. Trading on the OTCQB market enables companies to efficiently build broader investor awareness and provide US investors with a seamless trading facility to trade through the broker of their choice more easily.
READ: Ayurcann signs new partnership with California brand Green Bee Botanicals for the Canadian market
In a statement, Igal Sudman, the company's CEO commented: "Ayurcann is excited to provide US institutional and retail investors this opportunity to join our journey through the OTCQB. We love our Canadian roots, but our plans and visions include being traded in the largest economy on the planet and demonstrate our investment capabilities in manufacturing quality cannabis derivates at an affordable price while maintaining healthy operating margins."
The listing of the company's common shares on the OTCQB remains subject to the approval of the OTCQB and the satisfaction of applicable listing requirements. As more information becomes available, Ayurcann sait it will keep its shareholders up-to-date on the status of the application.
Ayurcann is a leading post-harvest solution provider with a focus on providing and creating custom processes and pharma-grade products for the adult-use and medical cannabis industry in Canada. It is striving to become a partner of choice for leading Canadian cannabis brands by providing best-in-class, proprietary services including ethanol extraction, formulation, product development and custom manufacturing.
Last week, Ayurcann announced a partnership agreement with California-based Green Bee Botanicals to produce CBD and THC-infused cannabis wellness products for the adult-use market in Canada, with sales set to begin in 2021. Green Bee Botanicals is a female-founded and owned company with an award-winning line of cannabis topicals, specifically designed to address women’s needs.
Contact the author at jon.hopkins@proactiveinvestors.com